{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:15:05Z","timestamp":1790615705432,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00213-017-4664-z","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T08:02:19Z","timestamp":1497859339000},"page":"2365-2374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse"],"prefix":"10.1007","volume":"234","author":[{"given":"Thomas","family":"Freret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Lelong-Boulouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lecouflet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Hamidouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Dauphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Boulouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"4664_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0091-3057(75)90182-3","volume":"3","author":"H Anisman","year":"1975","unstructured":"Anisman H (1975) Dissociation of disinhibitory effects of scopolamine: strain and task factors. Pharmacol Biochem Behav 3:613\u2013618. doi: 10.1016\/0091-3057(75)90182-3","journal-title":"Pharmacol Biochem Behav"},{"key":"4664_CR2","doi-asserted-by":"publisher","unstructured":"Birks JS\u00a0(2006)\u00a0Cholinesterase inhibitors for Alzheimer's disease.\u00a0Cochrane Database of Systematic Reviews\u00a02006, Issue\u00a01. Art. No.: CD005593. doi: 10.1002\/14651858.CD005593","DOI":"10.1002\/14651858.CD005593"},{"key":"4664_CR3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0022-3565(25)12928-5","volume":"277","author":"GM Bores","year":"1996","unstructured":"Bores GM, Huger FP, Petko W et al (1996) Pharmacological evaluation of novel Alzheimer\u2019s disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. J Pharmacol Exp Ther 277:728\u2013738","journal-title":"J Pharmacol Exp Ther"},{"key":"4664_CR4","unstructured":"Buccafusco JJ (2009) The revival of scopolamine reversal for the assessment of cognition-enhancing drugs. In: Buccafusco JJ (ed) Methods of behavior analysis in neuroscience, 2nd edn. Boca Raton, CRC Press\/Taylor & Francis, p 1\u20139"},{"key":"4664_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbr.2007.10.008","volume":"187","author":"M Cachard-Chastel","year":"2008","unstructured":"Cachard-Chastel M, Devers S, Sicsic S et al (2008) Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl\/6j mice. Behav Brain res 187:455\u2013461. doi: 10.1016\/j.bbr.2007.10.008","journal-title":"Behav Brain res"},{"key":"4664_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/jm7009364","volume":"51","author":"A Cavalli","year":"2008","unstructured":"Cavalli A, Bolognesi ML, Minarini A et al (2008) Multi-target-directed ligands to combat neurodegenerative diseases. J med Chem 51:347\u2013372. doi: 10.1021\/jm7009364","journal-title":"J med Chem"},{"key":"4664_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/14656566.2011.520702","volume":"12","author":"K Chopra","year":"2011","unstructured":"Chopra K, Misra S, Kuhad A (2011) Current perspectives on pharmacotherapy of Alzheimer\u2019s disease. Expert Opin Pharmacother 12:335\u2013350. doi: 10.1517\/14656566.2011.520702","journal-title":"Expert Opin Pharmacother"},{"key":"4664_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00213-011-2627-3","volume":"222","author":"V Silva Costa-Aze Da","year":"2012","unstructured":"Da Silva Costa-Aze V, Quiedeville A, Boulouard M, Dauphin F (2012) 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice. Psychopharmacology 222:99\u2013115. doi: 10.1007\/s00213-011-2627-3","journal-title":"Psychopharmacology"},{"key":"4664_CR9","doi-asserted-by":"crossref","unstructured":"De Jaco A, Bernardini L, Rosati J, Tata AM (2016) Alpha-7 nicotinic receptors in nervous system disorders: from function to therapeutic perspectives. Cent Nerv Syst Agents Med Chem.17:3\u00a0","DOI":"10.2174\/1871524916666160729111446"},{"key":"4664_CR10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0163-1047(93)90886-M","volume":"59","author":"RJ Fishkin","year":"1993","unstructured":"Fishkin RJ, Ince ES, Carlezon WA, Dunn RW (1993) D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats. Behav Neural Biol 59:150\u2013157","journal-title":"Behav Neural Biol"},{"key":"4664_CR11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0028-3908(97)00055-5","volume":"36","author":"DJ Fontana","year":"1997","unstructured":"Fontana DJ, Daniels SE, Wong EH et al (1997) The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation. Neuropharmacology 36:689\u2013696","journal-title":"Neuropharmacology"},{"key":"4664_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbr.2012.02.012","volume":"230","author":"T Freret","year":"2012","unstructured":"Freret T, Bouet V, Quiedeville A et al (2012) Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice. Behav Brain res 230:304\u2013308. doi: 10.1016\/j.bbr.2012.02.012","journal-title":"Behav Brain res"},{"key":"4664_CR13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0022-3565(24)37700-6","volume":"286","author":"N Galeotti","year":"1998","unstructured":"Galeotti N, Ghelardini C, Bartolini A (1998) Role of 5-HT4 receptors in the mouse passive avoidance test. J Pharmacol Exp Ther 286:1115\u20131121","journal-title":"J Pharmacol Exp Ther"},{"key":"4664_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.neubiorev.2004.06.006","volume":"28","author":"RN Hughes","year":"2004","unstructured":"Hughes RN (2004) The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav rev 28:497\u2013505. doi: 10.1016\/j.neubiorev.2004.06.006","journal-title":"Neurosci Biobehav rev"},{"key":"4664_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fnins.2016.00177","volume":"10","author":"RE Hughes","year":"2016","unstructured":"Hughes RE, Nikolic K, Ramsay RR (2016) One for all? Hitting multiple Alzheimer\u2019s disease targets with one drug. Front Neurosci 10:177. doi: 10.3389\/fnins.2016.00177","journal-title":"Front Neurosci"},{"key":"4664_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tins.2006.07.005","volume":"29","author":"I Izquierdo","year":"2006","unstructured":"Izquierdo I, Bevilaqua LRM, Rossato JI et al (2006) Different molecular cascades in different sites of the brain control memory consolidation. Trends Neurosci 29:496\u2013505. doi: 10.1016\/j.tins.2006.07.005","journal-title":"Trends Neurosci"},{"key":"4664_CR17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0028-3908(01)00123-X","volume":"41","author":"L Lamirault","year":"2001","unstructured":"Lamirault L, Simon H (2001) Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors. Neuropharmacology 41:844\u2013853","journal-title":"Neuropharmacology"},{"key":"4664_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0278-5846(02)00351-2","volume":"27","author":"L Lamirault","year":"2003","unstructured":"Lamirault L, Guillou C, Thal C, Simon H (2003) Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats. Prog Neuro-Psychopharmacol Biol Psychiatry 27:185\u2013195. doi: 10.1016\/S0278-5846(02)00351-2","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"4664_CR19","doi-asserted-by":"publisher","first-page":"E3825","DOI":"10.1073\/pnas.1410315111","volume":"111","author":"C Lecoutey","year":"2014","unstructured":"Lecoutey C, Hedou D, Freret T et al (2014) Design of donecopride, a dual serotonin subtype 4 receptor agonist\/acetylcholinesterase inhibitor with potential interest for Alzheimer\u2019s disease treatment. Proc Natl Acad Sci U S a 111:E3825\u2013E3830. doi: 10.1073\/pnas.1410315111","journal-title":"Proc Natl Acad Sci U S a"},{"key":"4664_CR20","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1093\/cercor\/bhu119","volume":"25","author":"M Leger","year":"2015","unstructured":"Leger M, Paizanis E, Dzahini K et al (2015) Environmental enrichment duration differentially affects behavior and neuroplasticity in adult mice. Cereb Cortex 25:4048\u20134061. doi: 10.1093\/cercor\/bhu119","journal-title":"Cereb Cortex"},{"key":"4664_CR21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0028-3908(01)00085-5","volume":"41","author":"V Lelong","year":"2001","unstructured":"Lelong V, Dauphin F, Boulouard M (2001) RS 67333 and D-cycloserine accelerate learning acquisition in the rat. Neuropharmacology 41:517\u2013522","journal-title":"Neuropharmacology"},{"key":"4664_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00210-003-0743-2","volume":"367","author":"V Lelong","year":"2003","unstructured":"Lelong V, Lhonneur L, Dauphin F, Boulouard M (2003) BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse. Naunyn Schmiedeberg's Arch Pharmacol 367:621\u2013628. doi: 10.1007\/s00210-003-0743-2","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"4664_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0531-5565(02)00157-2","volume":"38","author":"F Lezoualc\u2019h","year":"2003","unstructured":"Lezoualc\u2019h F, Robert SJ (2003) The serotonin 5-HT4 receptor and the amyloid precursor protein processing. Exp Gerontol 38:159\u2013166","journal-title":"Exp Gerontol"},{"key":"4664_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.med.57.121304.131442","volume":"57","author":"A Lle\u00f3","year":"2006","unstructured":"Lle\u00f3 A, Greenberg SM, Growdon JH (2006) Current pharmacotherapy for Alzheimer\u2019s disease. Annu rev med 57:513\u2013533. doi: 10.1146\/annurev.med.57.121304.131442","journal-title":"Annu rev med"},{"key":"4664_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuropharm.2014.05.013","volume":"85","author":"AC Lo","year":"2014","unstructured":"Lo AC, De Maeyer JH, Vermaercke B et al (2014) SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl\/6 mice. Neuropharmacology 85:178\u2013189. doi: 10.1016\/j.neuropharm.2014.05.013","journal-title":"Neuropharmacology"},{"key":"4664_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1124\/jpet.105.092262","volume":"316","author":"N Madjid","year":"2006","unstructured":"Madjid N, Tottie EE, L\u00fcttgen M et al (2006) 5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms. J Pharmacol Exp Ther 316:581\u2013591. doi: 10.1124\/jpet.105.092262","journal-title":"J Pharmacol Exp Ther"},{"key":"4664_CR27","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0028-3908(00)00038-1","volume":"39","author":"E Marchetti","year":"2000","unstructured":"Marchetti E, Dumuis A, Bockaert J et al (2000) Differential modulation of the 5-HT(4) receptor agonists and antagonist on rat learning and memory. Neuropharmacology 39:2017\u20132027","journal-title":"Neuropharmacology"},{"key":"4664_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0028-3908(97)00058-0","volume":"36","author":"E Marchetti-Gauthier","year":"1997","unstructured":"Marchetti-Gauthier E, Roman FS, Dumuis A et al (1997) BIMU1 increases associative memory in rats by activating 5-HT4 receptors. Neuropharmacology 36:697\u2013706. doi: 10.1016\/S0028-3908(97)00058-0","journal-title":"Neuropharmacology"},{"key":"4664_CR29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)38802-0","volume":"296","author":"M Matsumoto","year":"2001","unstructured":"Matsumoto M, Togashi H, Mori K et al (2001) Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J Pharmacol Exp Ther 296:676\u2013682","journal-title":"J Pharmacol Exp Ther"},{"key":"4664_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbr.2007.06.026","volume":"184","author":"A Meneses","year":"2007","unstructured":"Meneses A (2007) Stimulation of 5-HT1A, 5-HT1B, 5-HT2A\/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory. Behav Brain res 184:81\u201390. doi: 10.1016\/j.bbr.2007.06.026","journal-title":"Behav Brain res"},{"key":"4664_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.brainres.2006.08.108","volume":"1121","author":"V Micale","year":"2006","unstructured":"Micale V, Leggio GM, Mazzola C, Drago F (2006) Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia. Brain res 1121:207\u2013215. doi: 10.1016\/j.brainres.2006.08.108","journal-title":"Brain res"},{"key":"4664_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbr.2010.11.052","volume":"221","author":"J Micheau","year":"2011","unstructured":"Micheau J, Marighetto A (2011) Acetylcholine and memory: a long, complex and chaotic but still living relationship. Behav Brain res 221:424\u2013429. doi: 10.1016\/j.bbr.2010.11.052","journal-title":"Behav Brain res"},{"key":"4664_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.neuropharm.2007.06.016","volume":"53","author":"EG Mohler","year":"2007","unstructured":"Mohler EG, Shacham S, Noiman S et al (2007) VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux. Neuropharmacology 53:563\u2013573. doi: 10.1016\/j.neuropharm.2007.06.016","journal-title":"Neuropharmacology"},{"key":"4664_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1124\/jpet.102.034249","volume":"302","author":"PC Moser","year":"2002","unstructured":"Moser PC, Bergis OE, Jegham S et al (2002) SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties. J Pharmacol Exp Ther 302:731\u2013741. doi: 10.1124\/jpet.102.034249","journal-title":"J Pharmacol Exp Ther"},{"key":"4664_CR35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/156720509787602861","volume":"6","author":"G Pepeu","year":"2009","unstructured":"Pepeu G, Giovannini MG (2009) Cholinesterase inhibitors and beyond. Curr Alzheimer res 6:86\u201396","journal-title":"Curr Alzheimer res"},{"key":"4664_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0197-4580(81)90032-4","volume":"2","author":"EK Perry","year":"1981","unstructured":"Perry EK, Blessed G, Tomlinson BE et al (1981) Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol Aging 2:251\u2013256","journal-title":"Neurobiol Aging"},{"key":"4664_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000113691","volume":"5","author":"SJ Robert","year":"2008","unstructured":"Robert SJ, Lezoualc\u2019h F (2008) Distinct functional effects of human 5-HT4 receptor isoforms on beta-amyloid secretion. Neurodegener dis 5:163\u2013165. doi: 10.1159\/000113691","journal-title":"Neurodegener dis"},{"key":"4664_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbr.2011.01.055","volume":"221","author":"L Robinson","year":"2011","unstructured":"Robinson L, Platt B, Riedel G (2011) Involvement of the cholinergic system in conditioning and perceptual memory. Behav Brain res 221:443\u2013465. doi: 10.1016\/j.bbr.2011.01.055","journal-title":"Behav Brain res"},{"key":"4664_CR39","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1021\/acs.jmedchem.5b00115","volume":"58","author":"C Rochais","year":"2015","unstructured":"Rochais C, Lecoutey C, Gaven F et al (2015) Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer\u2019s disease: the design of donecopride. J med Chem 58:3172\u20133187. doi: 10.1021\/acs.jmedchem.5b00115","journal-title":"J med Chem"},{"key":"4664_CR40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00212843","volume":"94","author":"M Sarter","year":"1988","unstructured":"Sarter M, Bodewitz G, Stephens DN (1988) Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology 94:491\u2013495","journal-title":"Psychopharmacology"},{"key":"4664_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1586\/ern.10.43","volume":"10","author":"T Sobow","year":"2010","unstructured":"Sobow T (2010) Combination treatments in Alzheimer\u2019s disease: risks and benefits. Expert rev Neurother 10:693\u2013702. doi: 10.1586\/ern.10.43","journal-title":"Expert rev Neurother"},{"key":"4664_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0091-3057(88)90325-5","volume":"31","author":"JE Sweeney","year":"1988","unstructured":"Sweeney JE, H\u00f6hmann CF, Moran TH, Coyle JT (1988) A long-acting cholinesterase inhibitor reverses spatial memory deficits in mice. Pharmacol Biochem Behav 31:141\u2013147","journal-title":"Pharmacol Biochem Behav"},{"key":"4664_CR43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(89)90364-X","volume":"34","author":"JE Sweeney","year":"1989","unstructured":"Sweeney JE, Puttfarcken PS, Coyle JT (1989) Galanthamine, an acetylcholinesterase inhibitor: a time course of the effects on performance and neurochemical parameters in mice. Pharmacol Biochem Behav 34:129\u2013137","journal-title":"Pharmacol Biochem Behav"},{"key":"4664_CR44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02245921","volume":"102","author":"JE Sweeney","year":"1990","unstructured":"Sweeney JE, Bachman ES, Coyle JT (1990) Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice. Psychopharmacology 102:191\u2013200","journal-title":"Psychopharmacology"},{"key":"4664_CR45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00002512-200320100-00006","volume":"20","author":"G Wilcock","year":"2003","unstructured":"Wilcock G, Howe I, Coles H et al (2003) A long-term comparison of galantamine and donepezil in the treatment of Alzheimer\u2019s disease. Drugs Aging 20:777\u2013789","journal-title":"Drugs Aging"},{"key":"4664_CR46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1527-3458.2002.tb00237.x","volume":"8","author":"DS Woodruff-Pak","year":"2002","unstructured":"Woodruff-Pak DS, Lander C, Geerts H (2002) Nicotinic cholinergic modulation: galantamine as a prototype. CNS Drug Rev 8:405\u2013426","journal-title":"CNS Drug Rev"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4664-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:09:49Z","timestamp":1750360189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4664-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":46,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4664"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4664-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]}}}